Searchable abstracts of presentations at key conferences in endocrinology

ea0081p528 | Adrenal and Cardiovascular Endocrinology | ECE2022

The role of neuropeptide Y in the pathogenesis of vasovagal syncope

Lazurova Zora , Lazurova Ivica , Mitro Peter , Popovnakova Marcela

Introduction: Vasovagal syncope (VVS) is a transient loss of conscioussness due to hypoperfusion of the brain caused by vasodepressoric and/or cardioinhibitory reflex. In the pathogenesis, a dysregulation of autonomic nervous system is playing an important role. There is a growing evidence about more complex neurohumoral background of VVS. Neuropeptide Y (NPY) is hormone involved in the regulation of blood pressure with potent vasoconstriction effect. Moreover, NPY is also a c...

ea0081ep814 | Pituitary and Neuroendocrinology | ECE2022

Exploring a new entity of monotherapy pembrolizumab-associated hypophysitis

Balti Eric , Verhaeghe Sarah , Kruse Vibeke , Roels Stijn , Coremans Peter

Background: There are increasing number of reports on immune checkpoint inhibitors induced adverse events including hypophysitis. Hypophysitis tends to occur more with CytotoxicT-lymphocyte-associated protein 4 inhibitors (12-15% of cases) which is a different entity compared to those associated to anti-program death 1 (anti-PD1) inhibitors.Aim: We describe a case of pembrolizumab-associated hypophysitis and conduct a discussion based on a systematic rev...

ea0050oc2.2 | Clinical Highlights | SFEBES2017

Combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

Taylor Peter , Rajendram Rathie , Uddin Jimmy , Lee Richard , Dayan Colin

On behalf of the Combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) InvestigatorsBackground: Thyroid eye disease is an inflammatory orbital condition which causes visual dysfunction and psychological morbidity. Current evidence is conflicting on the benefit of radiotherapy and antiproliferative immunosuppression in addition to systemic corticosteroid treatment. In particular, little is known about clinical outcomes mor...

ea0050p268 | Neuroendocrinology and Pituitary | SFEBES2017

Disorganised anterior pituitary ultrastructure in choriogonadotrophin-alpha (Cga) null female mice

Davies Jessica , Gergics Peter , Camper Sally , Christian Helen

Choriogonadotrophin-alpha (Cga) is one of the first molecular markers for the developing pituitary gland previously known as ‘alpha-subunit’, common to thyroid-stimulating hormone (TSH), luteinising hormone (LH) and follicle-stimulating hormone (FSH). Mice lacking Cga are hypogonadal and exhibit profound hypothyroidism and dwarfism. Light microscopy of Cga null mice has shown that pituitary thyrotrophs...

ea0050p404 | Thyroid | SFEBES2017

The impact of a profoma introduction on the accuracy and appropriateness of Synacthen testing

Jarvis Peter , Partridge Helen , Holt Helen , Richardson Tristan , Page Georgina

Background: We previously reported that a high number of synacthen tests are carried inaccurately within our trust with a significant delay in sample collection after tetracosactide injection. We also reported a high number of patients having Synacthen tests unnecessarily. In light of this we introduced a Synacthen proforma and re-audited our results.Method: A retrospective study was carried out on 36 patients undergoing Synacthen tests bet...

ea0050ep071 | Neuroendocrinology and Pituitary | SFEBES2017

Cushing’s disease caused by pituitary macroadenoma exhibiting Crooke’s hyaline changes and immunoreactivity for adrenocorticotrophic hormone and growth hormone

Novodvorsky Peter , Ince Paul G , Sinha Saurabh , Debono Miguel

Introduction: Cushing’s disease is usually caused by functional corticotroph microadenomas of the pituitary. Crooke’s cell adenomas are rare, representing approximately 2% of corticotroph adenomas and mostly present as aggressive macroadenomas. Pituitary adenomas showing immunoreactivity for both ACTH and GH are also very uncommon. We present two cases of Cushing’s disease caused by macroadenomas with Crooke’s cell cha...

ea0050oc2.2 | Clinical Highlights | SFEBES2017

Combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

Taylor Peter , Rajendram Rathie , Uddin Jimmy , Lee Richard , Dayan Colin

On behalf of the Combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) InvestigatorsBackground: Thyroid eye disease is an inflammatory orbital condition which causes visual dysfunction and psychological morbidity. Current evidence is conflicting on the benefit of radiotherapy and antiproliferative immunosuppression in addition to systemic corticosteroid treatment. In particular, little is known about clinical outcomes mor...

ea0050p268 | Neuroendocrinology and Pituitary | SFEBES2017

Disorganised anterior pituitary ultrastructure in choriogonadotrophin-alpha (Cga) null female mice

Davies Jessica , Gergics Peter , Camper Sally , Christian Helen

Choriogonadotrophin-alpha (Cga) is one of the first molecular markers for the developing pituitary gland previously known as ‘alpha-subunit’, common to thyroid-stimulating hormone (TSH), luteinising hormone (LH) and follicle-stimulating hormone (FSH). Mice lacking Cga are hypogonadal and exhibit profound hypothyroidism and dwarfism. Light microscopy of Cga null mice has shown that pituitary thyrotrophs...

ea0050p404 | Thyroid | SFEBES2017

The impact of a profoma introduction on the accuracy and appropriateness of Synacthen testing

Jarvis Peter , Partridge Helen , Holt Helen , Richardson Tristan , Page Georgina

Background: We previously reported that a high number of synacthen tests are carried inaccurately within our trust with a significant delay in sample collection after tetracosactide injection. We also reported a high number of patients having Synacthen tests unnecessarily. In light of this we introduced a Synacthen proforma and re-audited our results.Method: A retrospective study was carried out on 36 patients undergoing Synacthen tests bet...

ea0050ep071 | Neuroendocrinology and Pituitary | SFEBES2017

Cushing’s disease caused by pituitary macroadenoma exhibiting Crooke’s hyaline changes and immunoreactivity for adrenocorticotrophic hormone and growth hormone

Novodvorsky Peter , Ince Paul G , Sinha Saurabh , Debono Miguel

Introduction: Cushing’s disease is usually caused by functional corticotroph microadenomas of the pituitary. Crooke’s cell adenomas are rare, representing approximately 2% of corticotroph adenomas and mostly present as aggressive macroadenomas. Pituitary adenomas showing immunoreactivity for both ACTH and GH are also very uncommon. We present two cases of Cushing’s disease caused by macroadenomas with Crooke’s cell cha...